UPDATE: Synergy Pharma (SGYP) Higher on Linzess Approval (IRWD) (FRX)
Tweet Send to a FriendGet Alerts FRX Hot Sheet
Down)
Trade FRX Now!
(Updated - August 30, 2012 11:36 AM EDT)
Synergy Pharmaceuticals (Nasdaq: SGYP) is moving higher following FDA approval for Linzess for Ironwood (Nasdaq: IRWD) and Forest Labs (NYSE: FRX). Shares are up 3 percent on the session.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Synergy Pharmaceuticals (Nasdaq: SGYP) is moving higher following FDA approval for Linzess for Ironwood (Nasdaq: IRWD) and Forest Labs (NYSE: FRX). Shares are up 3 percent on the session.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Forest Laboratories Inc. (FRX) to Bid for Elan (ELN)
- ReneSola (SOL) Pops on Pump Article
- Microsoft (MSFT) Announces Change to Xbox One Resell Rules (GME)
Create E-mail Alert Related Categories
FDA, Insiders' Blog, Trader Talk
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
